Gleevec, a brand of imatinib mesylate, is used in the treatment of Chronic Myeloid Leukemia, a rare form of cancer.
Related categories 1
Sites 5
Loading new listings for you to review...
- Gleevec Imatinib mesylate. Features prescribing and reimbursement information for US residents.
- Imatinib ( Glivec ) - International Site Manufacturer's information on this prescription medication used in the treatment of Chronic Myelogenous Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST).
- Life Raft Group Features newsletters from this group of patients who are taking part in the Gleevec trials to treat gastrointestinal stromal tumors, a form of cancer.
- Gleevec Information Features information from the FDA's Center for Drug Evaluation and Research including news releases, FAQs, approval letter, and draft package insert.
- MedlinePlus: Imatinib Features information about dosage, usage, warnings, and side effects.